Related Experiment Video
Updated: Mar 12, 2026

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
Published on: September 17, 2021
Impact of Microvascular Spasm on Coronary Physiological Assessment - Insights From Angiography-Derived Index of
Hikaru Shimosato1, Yoshihisa Kanaji1, Eisuke Usui1
1Cardiovascular Medicine, Tsuchiura Kyodo General Hospital Ibaraki Japan.
Background:
Microvascular spasm (MVS), a phenotype of microvascular dysfunction in patients with angina with non-obstructive coronary arteries (ANOCA), involves transient microvascular constriction. The angiography-derived index of microcirculatory resistance (A-IMR) is a less invasive method for assessing microcirculatory resistance. We aimed to evaluate MVS characteristics using A-IMR.
Methods And Results:
We retrospectively studied ANOCA patients who underwent acetylcholine spasm provocation tests (SPT). Patients were classified into no-spasm, epicardial spasm (ECS), or MVS groups. A-IMR was measured before and after SPT. Of 109 patients, 21 (19.3%) had MVS. The MVS group had more women (76.2% vs. 42.0%; P=0.01) than the other 2 groups combined. While pre-SPT A-IMR values were similar, post-SPT A-IMR after nitroglycerin was significantly higher in the MVS group than the no-spasm group, especially in the left anterior descending (LAD) artery (44.60 vs. 33.54; P=0.007). ∆A-IMR (post- minus pre-SPT) was significantly greater in the MVS group for both the LAD (9.89 vs. -9.26; P=0.001) and right coronary artery (RCA; 3.22 vs. -6.83; P=0.001). Multivariable analysis showed ∆A-IMR in the LAD and RCA were independently associated with MVS.
Conclusions:
Serial A-IMR assessment during SPT reveals sustained nitrate-resistant microvascular constriction in patients with MVS, which may confound standard post-SPT physiological assessments such as coronary flow reserve or IMR. These findings underscore the need for careful interpretation of physiological data in the presence of MVS.
Related Concept Videos
Vascular Spasm
Acute Coronary Syndrome III: Diagnostic Studies
Measurement of Blood Pressure
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

